Disclosures for "Cognito’s non-invasive medical device demonstrates durable effects on activities of daily living through OVERTURE open-label extension study."
-
Dr. Kern has received personal compensation for serving as an employee of Cognito Therapeutics.
-
Mr. Kuang has received personal compensation for serving as an employee of Cognito.
-
Prof. Hajos has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. Prof. Hajos has stock in Cognito Therapeuitcs. Prof. Hajos has stock in Biogen. Prof. Hajos has stock in Pfizer. Prof. Hajos has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Therapeutics has received personal compensation for serving as an employee of Cognito Therapeutics. An immediate family member of Ms. Therapeutics has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cognito Therapeutics. Ms. Therapeutics has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Boasso has received personal compensation for serving as an employee of Cognito Therapeutics.
-
Mr. Hempel has received personal compensation for serving as an employee of Cognito Therapeutics.
-
Mr. Vaughan has received personal compensation for serving as an employee of Morningside . Mr. Vaughan has received personal compensation for serving as an employee of Kuzani Pharmaceuticals, Inc.. Mr. Vaughan has received personal compensation for serving as an employee of Cognito Therapeutics, Inc..
-
Mr. Seshagiri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognito Therapeutics. Mr. Seshagiri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for OXYS-IIOT. Mr. Seshagiri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Emeritus.
-
Mr. Malchano has received personal compensation for serving as an employee of Cognito Therapeutics, Inc.. Mr. Malchano has received stock or an ownership interest from Cognito Therapeutics.
-
Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara.
-
-
Mr. Massey has nothing to disclose.
-